US Patent 11179364 Licofligozin for the treatment of non-alcoholic steatohepatitis

Patent 11179364 was granted and assigned to Novartis on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Novartis

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111793640

Patent Inventor Names

Lloyd Klickstein0

C. Daniel Meyers0

Chinweike Ukomadu0

Date of Patent

November 23, 2021

Patent Application Number

166245270

Date Filed

June 20, 2018

Patent Primary Examiner

‌

Shengjun Wang

Patent abstract

The disclosure concerns the use of LIK066 in the treatment, prevention or delay of non-alcoholic steatohepatitis.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11179364 Licofligozin for the treatment of non-alcoholic steatohepatitis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API